The Brand

Not a startup bet.
A legacy brand's move
into a contested category.

Verdant Foods has built its reputation in refrigerated protein — turkey, chicken, family-format proteins — in 4,000+ retail doors. The brand is trusted, mainstream, and shelf-proven. Plant-based is a natural adjacency, but not a natural advantage.

The question was not whether Verdant could make a plant-based product. The question was whether a conventional protein brand could enter a flat, scrutiny-heavy category and actually win. And if so, how — and for whom.

"The brand that mastered the meat section now wants to own the meat-alternative one. The question is whether those are the same buyer."

The Decision

Refrigerated plant-based launch in the next 6–12 months — or wait.

Go/no-go with projected pricing, segment targeting, and market sequence. A real capital commitment decision with a live category clock.

What Was at Stake

A flat category, entrenched incumbents, and one company's ability to prove that mainstream protein trust can lower the barrier to plant-based trial.

Beyond Meat and Impossible Foods define the category. Verdant's only edge is trust — and trust only converts if taste and price hold. The stakes are real and the window is narrow.

How Fisga Worked

01
Brief onboarding

Figgy captured the launch decision, target pricing, segment hypotheses, and priority markets through a structured conversation. No briefs. No back-and-forth.

02
Federal panel generation

1,000 consumer profiles across 13 buyer segments — from plant-based loyalists to meat-reducers to skeptical conventional buyers — grounded in Census, BLS, FRED, CDC BRFSS, and GSS data.

03
Confidence-based modeling

Statistical ranges across 3 primary segments, 4 launch markets, and 6 pricing scenarios ($5.99–$9.99). Every finding expressed as a range with a stated confidence level.

04
Content Studio activation

Outputs converted into a retailer sell-in brief, segment messaging framework, and pricing rationale deck — all grounded in the same federal dataset.

Fifteen minutes. A go/no-go for a nine-figure market.

The study ran in fifteen minutes. Not because Fisga cut corners — because the infrastructure for this analysis already existed. The consumer panel, the federal grounding, the pricing model, the segment taxonomy. It was built before Verdant walked in.

What took traditional research firms six to eight weeks — panel recruitment, questionnaire design, fielding, cross-tab analysis — Fisga compressed into a single structured run. The insight quality is the same. The wait is not.

Every insight has a source

Real data. Not AI guessing.

Fisga's consumer intelligence is grounded in federal data — not AI guessing. Every synthetic consumer profile traces to a named public dataset. Every price range is calibrated against real household economics. Every segment reflects observed purchasing behavior.

U.S. Census Federal Labor Data Economic Data Search Signals Health & Behavior Data Social Survey Data

What the Panel Found

68% said yes.
But the category is flat.
And taste could kill it.

National stated purchase intent landed at 3.67–3.76 out of 5, with 68.8%–74.8% of the panel at high-intent. That is a strong concept signal. But Fisga's finding was more nuanced: the enthusiasm was conditional. Not "I want this." But "I want this — if it actually tastes good, if the price is fair, and if I can trust the label."

Meat-reducers and current plant-based buyers were the strongest respondents. Skeptical conventional buyers were largely unmovable. The realistic conversion rate from stated intent to actual in-market trial: 20%–35% of target households — not 68%. The difference is what a Fisga study is designed to surface.

68.8%
High-intent shareOf the panel at high purchase intent — 3.72/5 avg score
20.9%
Top barrier: priceMaking this the single largest conversion obstacle in the study
37.0%
Need proofRequire proof on ingredients, health, or nutrition before trial

"I would try it. But I need it to actually taste like meat — not a science project. That's the whole game."

Meat-reducer, Texas

"I already buy Beyond once in a while. If Verdant is cleaner, priced right, and in H-E-B, I'd switch."

Occasional plant-based buyer, Houston

The Three Segments

Fisga found thirteen segments.
Three determine the launch.
One determines the outcome.

The panel produced 13 distinct buyer profiles. But for Verdant's launch decision, three segments define the entire strategy — because they have fundamentally different purchase conditions, conversion economics, and strategic value.

Segment 01 — Primary Target

Meat-Reducers

Health-motivated, family-feeding households already rotating between lean proteins. They are the reason to launch.

Trial propensity
25%–40%
Repeat potential
15%–25%

Converts on: Taste parity, fair price, clean label, familiar meal usage (tacos, spaghetti, burgers)

"Verdant's refrigerated-protein heritage lowers perceived risk for this segment more than for any other."

"I already rotate turkey, chicken, and beans. If this tastes right and isn't overpriced, it fits." — Jessica Martinez, Houston TX

Segment 02 — Credibility Segment

Current Plant-Based Buyers

Weekly or regular plant-based buyers who set category standards and amplify word-of-mouth.

Trial propensity
55%–75%
Repeat potential
25%–45%

Converts on: Cleaner ingredients vs incumbents, taste parity, newness signal

"Highest trial odds, but harder to retain if Verdant is merely comparable to Beyond or Impossible."

"I buy plant-based weekly. Verdant would need to earn its place on my list — better label, better taste." — Emily Chen, Seattle WA

Segment 03 — Defer

Skeptical Conventional Buyers

Meat-first households open to plant-based only under heavy incentive or social pressure.

Trial propensity
5%–15%
Repeat potential
3%–8%

Converts on: Deep discount, social proof, doctor/family pressure only

"The largest theoretical pool with the worst near-term economics. Not the launch focus."

"I'd only try it if it was on deep discount and my doctor told me to." — Derek Thompson, Dallas TX

Two risks can kill this launch — taste failure and weak repeat. Verdant should gate expansion on both, and treat everything else as execution risk.

The Pricing Reality

The panel said $6.99.
The cliff lives at $8.99.
Everything above that is a different product.

Price is the single largest barrier — cited by 20.9% of respondents as the top obstacle. The panel anchors willingness to pay around $6–$10, with the credible launch band centered at $6.99–$7.49 for patties and $5.99–$6.49 for 1 lb ground.

Beyond Meat and Impossible Foods define the reference set for 57.5% of price-anchored respondents. Above $8.99 for patties, mainstream trial drops sharply — not because consumers can't pay, but because the product crosses from "worth trying" to "worth proving first."

The recommendation: enter at a slight value edge to incumbents, then earn pricing power through repeat. Promotional depth should be planned but time-limited — the economics break under permanent promo dependency.

Launch price architecture — national panel
1 lb Ground — recommended launch price $5.99–$6.49
Patties — optimal for mainstream grocery $6.99–$7.49
Premium channel ceiling $7.99
Price cliff — trial drops sharply above here $8.99+
AVOID — mainstream trial collapses above this point

Launch Sequence

Four markets scored.
One must come first.
One must wait.

Fisga scored each launch market across segment fit, retail infrastructure, competitive intensity, and Verdant's existing distribution footprint. The scoring produced a clear launch sequence — not a portfolio recommendation.

Texas returned the highest score at 7.6, driven by strong meat-reducer density, H-E-B retail infrastructure, existing Verdant distribution, and a meat-adjacent food culture that lowers product skepticism. California and the Pacific Northwest follow, with stronger plant-based credibility but higher incumbent entrenchment.

Texas 7.6/10
CA / WA 6.6/10
NY/IL/CO urban 6.4/10
National rollout After pilot proof
6.5/10
Year 1 Projection — Texas First

$4M–$17M SOM revenue.

60k–180k serviceable households at most-likely conversion. Repeat rate is the financial gate — 30%–40% of triers must repurchase to make the economics work at scale.

CAC Estimate

$12–$25 per acquired household in a disciplined regional launch.

Rises to $25–$40 in a broad national push. The economics work with targeted acquisition — they break under heavy promotional dependency. In-store sampling is the most efficient acquisition channel in this category.

The Repeat Threshold

Halt expansion if repeat falls below one-third of triers by day 90.

Verdant should gate expansion if repeat falls below roughly one-third of triers at the 90-day mark. That is the single operating gate that separates a viable adjacency from a costly me-too launch.

Content Studio

Study findings.
Converted into the
documents you actually need.

The same federal dataset that produced the segment findings and pricing architecture also powers the Content Studio. Outputs are converted into retailer sell-in briefs, segment messaging frameworks, and pricing rationale documents — deliverable-ready, not directional summaries.

Every document traces to the same grounded sources as the study itself. There is no gap between the research and the document — they are the same argument, in two different formats.

Fisga Content Studio — Verdant Foods · Retailer Brief
Retailer Sell-In Brief
Why the refrigerated meat set needs a trusted protein brand in plant-based — and what Verdant brings to the conversation.
The shopper we are both after is already in your refrigerated protein section. They buy your turkey. They buy your chicken. Ninety days from now, they will be looking at plant-based alternatives — because their doctor told them to, or their family asked them to, or they simply want a familiar meal with less meat. Right now, that shelf moment belongs to Beyond and Impossible. Verdant changes that. Not by out-innovating the specialists, but by being the brand these shoppers already trust in a format they already know.
Grounded in federal data n=1,000 profiles 13 segments Fisga Feasibility · May 2026

The Decision

GO — medium confidence.
Texas first. Meat-reducers first.
Prove repeat before you scale.
Or don't scale at all.

The Fisga study found enough signal to launch. Not to bet the company on — but enough to build a focused regional test with clear expansion gates. The category is flat. The incumbents are entrenched. The risk of a bad first bite is existential. But the opportunity for a trusted mainstream protein brand to convert health-motivated meat-reducers is real.

Channel Decision

Texas mainstream grocery first. H-E-B, Walmart, plus one Kroger/Albertsons banner.

Purpose: prove mainstream meat-reducer conversion before investing in premium channel credibility. Refrigerated placement is non-negotiable — this is not a freezer SKU.

Segment Decision

Meat-reducers as primary. Current plant-based buyers as secondary credibility segment.

Do not target skeptical conventional buyers in the first 12 months. They are a future segment, not a launch segment. Messaging should speak to familiar meals and trusted protein — not environmental positioning.

Pricing Decision

$5.99–$6.49 ground. $6.99–$7.49 patties. Below the price cliff.

Aggressive sampling and coupons for price-gated buyers. Planned promo depth with a defined exit timeline — promo dependency at month six is a failure signal, not a channel strategy.

The Gate

30/60/90/180-day checkpoints — before any expansion decision.

30-day: distribution lands. 60-day: 25%–35% repeat from triers. 90-day: 1 lb ground outperforms patties in velocity. 180-day: repeat stabilizes above one-third of triers and promo dependency declines.

Next Steps

Seven actions.
Thirty days to prove
the launch is ready.

Fisga's study produced a go decision. But a go decision is only as good as the execution plan that follows it. These are the seven actions Verdant should take before a single case ships.

01

Confirm launch thesis

Owner: GM / Strategy Timeline: 2 weeks

Approve business case with segment-specific goals and stop/go gates. Establish what "success" looks like at 30, 60, 90, and 180 days before any budget is committed.

02

Benchmark product vs incumbents

Owner: R&D + Commercial Timeline: 4–6 weeks

Blind taste test vs Beyond and Impossible. Do not launch unless parity or better on at least 2 of 3 sensory measures. Taste failure is existential in this category — test early, test blind.

03

Lock pricing architecture

Owner: Pricing / Revenue Management Timeline: 3 weeks

$6.99–$7.49 patties, $5.99–$6.49 ground, with planned promo depth and duration. Define the promotional exit date before the promotional start date.

04

Secure Texas retailers

Owner: Sales / Channel Timeline: 4 weeks

Confirm H-E-B, Walmart, plus one additional banner. Refrigerated set placement and sampling windows. The Fisga retailer brief is the sell-in document — use it.

05

Build packaging and claims

Owner: Brand / Creative Timeline: 4 weeks

Front-of-pack: protein grams, sodium transparency, familiar meal usage. Not sustainability-first — the meat-reducer segment converts on health and taste, not environmental claims. Lead with what moves them.

06

Design trial engine

Owner: Growth / Shopper Marketing Timeline: 6 weeks

In-store sampling, digital coupons, retailer media, influencer seeding with meat-reducer aligned accounts. Target CAC: $12–$25. Track cost per acquired household from day one.

07

Stand up launch dashboard

Owner: Analytics / Finance Timeline: Before launch

Track trial, repeat, velocity, promo dependency, and retailer reorders at 30/60/90/180 days. The dashboard is not optional — the go decision was conditional on expansion gates. Those gates cannot be enforced without data. Build it before the first case ships.

Independent Validation

We ran this study.
Then we checked it
against the public record.

One of the most important questions a synthetic panel study can answer is not just what the data says — it is whether the data can be trusted. After completing the Verdant feasibility study, Fisga cross-referenced its core findings against three independently published public datasets: the Good Food Institute's 2023 U.S. Plant-Based Food State of the Industry Report, the SPINS retail scanner data on refrigerated plant-based category performance, and the USDA Economic Research Service consumer survey on protein purchasing behavior.

Finding 01

Purchase Intent Alignment

Fisga Finding

68.8%–74.8% high stated intent among target households

GFI 2023 Public Data

37% of U.S. households purchased plant-based meat at least once in the past year; 58% of Millennials reported openness to trying new plant-based products

Assessment

Fisga's high-intent range reflects a target audience that has already self-selected for openness — consistent with GFI's finding that intent is significantly higher among already-engaged households vs. the general population. The gap between 37% and 68% is explained by segment filtering — Verdant is not targeting all U.S. households.

Finding 02

Price Sensitivity Alignment

Fisga Finding

Price cliff at ~$8.99; optimal band $6.99–$7.49 patties

SPINS / Nielsen Data

Average retail price for branded refrigerated plant-based patties in 2023–2024: $7.49–$8.99 per unit. Category velocity declines measurably above $9.49.

Assessment

Fisga's price cliff at $8.99 aligns closely with observed SPINS velocity drop-offs above the $9.49 price point. The recommended launch band of $6.99–$7.49 sits squarely within the observed optimal velocity range for category entry-level SKUs.

Finding 03

Segment Behavior Alignment

Fisga Finding

Meat-reducers as primary segment; skeptical conventional buyers low-probability near-term

USDA ERS + GFI Data

39% of plant-based category volume comes from households that describe themselves as "trying to eat less meat." Only 8%–12% of category volume comes from households with no history of plant-based trial.

Assessment

Strong alignment. Fisga's segment hierarchy mirrors the observed purchase distribution in public data: meat-reducers drive the most volume, pure skeptics contribute least.

The alignment between Fisga's synthetic panel and published public datasets validates the study's core conclusions. The methodology — grounding 1,000 synthetic consumer profiles in Census, BLS, FRED, CDC BRFSS, and GSS data — produces findings that match independently observed market behavior at the category level, while offering segment-level precision that aggregate public data cannot. This is the difference between directional research and defensible research.

Keep Exploring

Another decision.
Another answer.

View all studies →